Novartis’ Fabhalta® Meets Phase III Goal, Slows Kidney Decline in IgA Nephropathy
Novartis’ Fabhalta® (Iptacopan) Achieves Positive Phase III Results, Marking Major Progress in Slowing Kidney Function Decline in Patients With IgA Nephropathy Novartis announced encouraging final results from its pivotal Phase…
Roche Showcases Breakthroughs in Sequencing by Expansion and Sets New World Record at ASHG 2025
Roche Showcases Breakthrough Sequencing by Expansion (SBX) Technology and Sets New GUINNESS WORLD RECORD™ at ASHG 2025 Roche (SIX: RO, ROG; OTCQX: RHHBY) unveiled a series of groundbreaking advancements in…
Merck’s KEYNOTE-B96 Trial Meets OS Goal in Platinum-Resistant Ovarian Cancer
Merck’s Phase 3 KEYNOTE-B96 Trial Achieves Key Milestone in Platinum-Resistant Ovarian Cancer, Demonstrating Survival Benefit in All-Comer Population Merck (NYSE: MRK), known as MSD outside of the United States and…
Pulse Biosciences Announces Nasdaq Inducement Grants
Pulse Biosciences Grants Inducement Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4) Pulse Biosciences, Inc. (Nasdaq: PLSE), a bioelectric medicine company pioneering applications of its proprietary Nanosecond Pulsed Field…
Digitail and CDMV Partner to Enhance Veterinary Care
Digitail and CDMV Partner to Streamline Veterinary Operations and Improve Patient Care Across Canada Digitail, the industry’s leading AI-native veterinary practice information management system (PIMS), has announced a strategic integration…
bioAffinity Technologies Restores Nasdaq Compliance
bioAffinity Technologies Restores Nasdaq Compliance, Strengthening Path Toward Long-Term Growth bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company dedicated to advancing early-stage cancer diagnostics, announced that it has successfully…
Adagio Medical Prices Up to $50M Private Placement
Adagio Medical Announces Up to $50 Million Private Placement to Advance Cardiac Arrhythmia Therapies Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or the “Company”), a leading innovator in the development…
City of Hope Honors Tom Corson with Michael Bublé Performance and Cher Appearance
Music Industry Icons Unite to Celebrate Tom Corson at City of Hope’s Spirit of Life Gala, Raising Funds to Advance Cancer Research, Survivorship Programs, and Integrative Therapies one of the…
TP et l’UNICEF Renouvellement de Partenariat Humanitaire
TP and UNICEF Renew Partnership to Advance Education and Humanitarian Support Globally TP (formerly Teleperformance), a global leader in enterprise digital solutions, and UNICEF have announced the renewal of their…
SelectQuote Research Reveals Critical Gaps in Healthcare, Urges Personalized Solutions
SelectQuote Research Reveals Critical Gaps in Medicare Care, Underscoring Need for Personalized Healthcare Solutions OVERLAND PARK, Kan.–(BUSINESS WIRE)–SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and the…
Viatris Acquires Aculys Pharma, Securing Pitolisant and Spydia® Rights in Japan & Asia-Pacific
Viatris Expands CNS Portfolio in Japan with Acquisition of Aculys Pharma, Gaining Exclusive Rights to Pitolisant and Spydia® Viatris Inc. (Nasdaq: VTRS), a leading global healthcare company, today announced the…
WuXi Biologics Celebrates Sonoma Biotherapeutics’ Fred Ramsdell, PhD, 2025 Nobel Laureate
Transforming Autoimmune and Inflammatory Disease Therapies WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), proudly congratulates Dr. Fred Ramsdell, PhD, co-founder and Chair of the…